An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery—the BUMPER study

BACKGROUND: Patients with melanoma brain metastasis (MBM) still carry a dismal prognosis. Preclinical data originated in xenograft models showed that buparlisib therapy was highly effective in therapy-naïve MBM. PATIENTS AND METHODS: In this open-label, phase II trial, we investigate the safety and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Adv
Main Authors: Amaral, Teresa, Niessner, Heike, Sinnberg, Tobias, Thomas, Ioannis, Meiwes, Andreas, Garbe, Claus, Garzarolli, Marlene, Rauschenberg, Ricarda, Eigentler, Thomas, Meier, Friedegund
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7712798/
https://ncbi.nlm.nih.gov/pubmed/33305271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa140
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados